Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Depomed, Inc.

June 2026

Depomed, Inc. Market Share Analysis for June 2026

Year Founded1995
Employees201 - 500
Annual Revenue--
depomed.com
Depomed, Inc.
Depomed, Inc. (including company regionals)
  • depomed.com
    depomed.com
See more website traffic and engagement information

Total visits to Depomed, Inc.'s top domains

Understand Depomed, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Depomed, Inc.'s top domains

Analyze Depomed, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Depomed, Inc.'s top domains

See how Depomed, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Depomed, Inc.

These are the website technologies, by industry, used by Depomed, Inc. top domains

Widget (2)

Google Maps

Google Maps

Audio Video Media (1)

Vimeo

Vimeo

Content Management System (1)

WordPress

WordPress

Conversion & Analytics (1)

Google Analytics

Google Analytics

More Technologies

2

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Depomed, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJanssen Pharmaceuticals, Inc. sold assets to Depomed, Inc. on Apr 1st '17.Janssen Pharmaceutical sold its license of marketing and distribution of the U.S. to Depomed, Inc. and in April 2017, Depomed, Inc. won the patent for tapentadol.
NewsDepomed, Inc. hired John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications on Apr 17th '18.Depomed, Inc. (NASDAQ: DEPO ) today announced the appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications, effective immediately.
NewsDepomed, Inc. hired Stan Bukofzer as Senior Vice President, Chief Medical and Scientific Officer on Apr 2nd '18.Depomed has hired Stan Bukofzer, M.D., an Abbott veteran who also served in VP spots at Astellas and Hospira, as its senior vice president and chief medical and scientific officer.

See all Depomed, Inc. signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.